Leapin' lizards: Amylin targets diabetes and obesity via incretins.
Wolfson
Wendy
W
wendywolfson@nasw.org
D000682:Amyloid / Q000627:therapeutic use*; D019440:Anti-Obesity Agents / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D058228:Islet Amyloid Polypeptide; D008019:Life Style; D009765:Obesity / Q000188:drug therapy*
D000682:Amyloid; D019440:Anti-Obesity Agents; D007004:Hypoglycemic Agents; D058228:Islet Amyloid Polypeptide